Has Vinayak Belamkar, MD received payments from drug or device companies?

Yes. Drug and device makers reported $27,841 in general payments to Vinayak Belamkar, MD across 343 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Vinayak Belamkar, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Vinayak Belamkar, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Vinayak Belamkar, MD

Interventional Pain Medicine · Indianapolis, INNPI 1972586568

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (43.0%), travel and lodging and entertainment — rather than concentrated in one kind of arrangement. 44 manufacturers reported payments, led by Stimwave Technologies Incorporated at 34.4% of the total. Reporting peaked in 2019 at $13,008 and has fallen 88.8% since, to $1,463 in 2025. Among interventional pain medicine clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$27,841in general payments, 2019–2025

Across 343 payments — averaging $81.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stimwave Technologies Incorporated$10K
Genesys Orthopedics Systems, L.L.C.$5K
Nevro Corp.$3K
Flowonix Medical Incorporated$2K
Spinal Simplicity, LLC$1K
MDD US Operations, LLC$1K
plus $6K from 38 others

What the payments were for

Consulting fees$2,0007%
Travel & lodging$9,20533%
Food & beverage$11,98143%
Gifts$2641%
Entertainment$4,39216%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stimwave Technologies Incorporated	31	$9,576
Genesys Orthopedics Systems, L.L.C.	20	$4,813
Nevro Corp.	62	$3,024
Flowonix Medical Incorporated	1	$1,704
Spinal Simplicity, LLC	9	$1,300
MDD US Operations, LLC	24	$1,004
Vertos Medical, Inc.	13	$671
Boston Scientific	18	$517
Globus Medical	5	$500
AbbVie(2 entities)	22	$420
Radius Health, Inc.	18	$420
GRT US Holding, Inc.	9	$392
SPR Therapeutics, Inc	8	$386
Abbott	10	$367
Collegium Pharmaceutical, Inc.	13	$221
Amgen	9	$206
Curonix LLC	2	$205
Si-bone, Inc.	7	$191
Vertex	4	$185
Tersera Therapeutics LLC	7	$175
Biohaven Pharmaceuticals, Inc.	4	$168
Medtronic(3 entities)	5	$156
Saluda Medical Americas, Inc.	1	$151
MML US, Inc.	2	$126
Biohaven Pharmaceutical Holding Company Ltd.	1	$125
Surgentec	1	$112
Spinefrontier, Inc.	1	$80
Pfizer	5	$78
Assertio Therapeutics, Inc.	4	$74
Novartis	4	$68
Masimo Corporation	2	$63
Painteq LLC	3	$59
Biodelivery Sciences International, Inc.	3	$47
Pacira Therapeutics, Inc.	2	$46
Daiichi Sankyo Inc.	3	$42
Averitas Pharma Inc.	2	$31
Almatica Pharma LLC	1	$29
Pacira Pharmaceuticals Incorporated	1	$22
Teva Pharmaceuticals USA, Inc.	1	$19
Valinor Pharma, LLC	1	$16
Scilex Pharmaceuticals Inc.	1	$15
Crossroads Orthopedics, LLC	1	$14
Lilly USA, LLC	1	$13
Vertiflex, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,841 in reported general payments places this provider in the 90th percentile of 68 interventional pain medicine providers in Indiana.

See all interventional pain medicine providers in Indiana →

Medicare billing

Part B allowed, 2024

$228,715

Medicare patients

138

Services billed

3,491

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Buprenorphine	35	$9,945
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	411	$9,508
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	218	$6,090
Fentanyl	23	$3,038
Oxycodone Hcl	107	$2,936
Gabapentin	67	$1,020
Pregabalin	46	$970
Methadone Hcl	22	$578
Hydromorphone Hcl	33	$497
Morphine Sulfate ErMorphine Sulfate	17	$390
Methocarbamol	12	$222
Tramadol Hcl	29	$171
Cyclobenzaprine Hcl	33	$143
Amitriptyline Hcl	11	$132
Alprazolam	11	$127

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Indianapolis

David GordonIndianapolis$28K
Jocelyn BushIndianapolis$20K
Edward KowlowitzIndianapolis$15K
Ashley TolbertIndianapolis$15K
Kristin GossIndianapolis$7K
Caroline AsavaIndianapolis$3K
Keiona WallerIndianapolis$3K
Michael DorwartIndianapolis$3K
Dena SeifertIndianapolis$2K
David RatzmanIndianapolis$1K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →